He Wanyi, Chen Congli, Cai Runjie, Zheng Jiwei, Yao Mengyu, Shim Joong Sup, Kwok Hang Fai, Yao Xiaojun, Fang Lijing, Chen Liang
Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China; School of Pharmacy, Changzhou University, Changzhou, Jiangsu Province, China.
J Biol Chem. 2025 May;301(5):108482. doi: 10.1016/j.jbc.2025.108482. Epub 2025 Apr 7.
As an important therapeutic target, carbonic anhydrase IX (CAIX) is crucial in the pH regulation of hypoxic solid tumors, thus keeping the survival of them in acidic microenvironment and promoting their proliferation, invasion, and metastasis. To degrade endogenous CAIX, three bifunctional compounds were designed according to the integrin-facilitated lysosomal degradation strategy. These compounds are composed of a CAIX-binding ligand, an integrin-recognizing ligand, connected via a linker, which could induce CAIX degradation in an integrin- and lysosome-dependent manner. Among them, Sul-L1-RGD showed the highest degradation efficacy and could inhibit the proliferation of tumor cells under hypoxic conditions, thus it has great potential to be applied in cancer drug discovery.
作为一个重要的治疗靶点,碳酸酐酶IX(CAIX)在缺氧实体瘤的pH调节中起着关键作用,从而使其在酸性微环境中存活,并促进其增殖、侵袭和转移。为了降解内源性CAIX,根据整合素介导的溶酶体降解策略设计了三种双功能化合物。这些化合物由一个CAIX结合配体、一个整合素识别配体组成,通过一个连接子连接,能够以整合素和溶酶体依赖的方式诱导CAIX降解。其中,Sul-L1-RGD表现出最高的降解效率,并且能够在缺氧条件下抑制肿瘤细胞的增殖,因此在癌症药物研发中具有巨大的应用潜力。